Combination Therapy for Diabetic Macular Edema

Diabetic macular edema is a main reason for visual loss in diabetic patients. Until recent years, macular laser photocoagulation was the only available therapy. The awareness that inflammation is an important factor in the pathogenetic process of DME gave reason for intravitreal treatment with corti...

Descripción completa

Detalles Bibliográficos
Autores principales: Zur, Dinah, Loewenstein, Anat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317224/
https://www.ncbi.nlm.nih.gov/pubmed/22523648
http://dx.doi.org/10.1155/2012/484612
_version_ 1782228532543356928
author Zur, Dinah
Loewenstein, Anat
author_facet Zur, Dinah
Loewenstein, Anat
author_sort Zur, Dinah
collection PubMed
description Diabetic macular edema is a main reason for visual loss in diabetic patients. Until recent years, macular laser photocoagulation was the only available therapy. The awareness that inflammation is an important factor in the pathogenetic process of DME gave reason for intravitreal treatment with corticosteroids. The introduction of anti-VEGF drugs brought a revolutionary change in the treatment of DME. This paper will review the important clinical trials with an emphasis on combination therapies.
format Online
Article
Text
id pubmed-3317224
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-33172242012-04-20 Combination Therapy for Diabetic Macular Edema Zur, Dinah Loewenstein, Anat J Ophthalmol Review Article Diabetic macular edema is a main reason for visual loss in diabetic patients. Until recent years, macular laser photocoagulation was the only available therapy. The awareness that inflammation is an important factor in the pathogenetic process of DME gave reason for intravitreal treatment with corticosteroids. The introduction of anti-VEGF drugs brought a revolutionary change in the treatment of DME. This paper will review the important clinical trials with an emphasis on combination therapies. Hindawi Publishing Corporation 2012 2012-03-07 /pmc/articles/PMC3317224/ /pubmed/22523648 http://dx.doi.org/10.1155/2012/484612 Text en Copyright © 2012 D. Zur and A. Loewenstein. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Zur, Dinah
Loewenstein, Anat
Combination Therapy for Diabetic Macular Edema
title Combination Therapy for Diabetic Macular Edema
title_full Combination Therapy for Diabetic Macular Edema
title_fullStr Combination Therapy for Diabetic Macular Edema
title_full_unstemmed Combination Therapy for Diabetic Macular Edema
title_short Combination Therapy for Diabetic Macular Edema
title_sort combination therapy for diabetic macular edema
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317224/
https://www.ncbi.nlm.nih.gov/pubmed/22523648
http://dx.doi.org/10.1155/2012/484612
work_keys_str_mv AT zurdinah combinationtherapyfordiabeticmacularedema
AT loewensteinanat combinationtherapyfordiabeticmacularedema

Ejemplares similares